Long-Term Liabilities: The sum of all non-current liabilities.
Ligand Pharmaceuticals Incorporated (LGND) had Long-Term Liabilities of $74.22M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$167.13M |
|
$-4.03M |
|
$11.07M |
|
$156.06M |
|
$189.74M |
|
$-22.61M |
|
$25.12M |
|
$2.52M |
|
$-72.51M |
|
$-4.03M |
|
$-4.03M |
|
$-4.03M |
|
$-274.21M |
|
$-22.61M |
|
$11.79M |
|
18.29M |
|
18.29M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$331.56M |
|
$15.13M |
|
$610.22M |
|
$941.77M |
|
$37.11M |
|
-- |
|
|
Long-Term Liabilities |
$74.22M |
$111.33M |
|
$830.44M |
|
$458.54M |
|
$830.44M |
|
19.11M |
|
| Cash Flow Statement Financials | |
$97.05M |
|
$-143.66M |
|
$97.14M |
|
$22.95M |
|
$72.31M |
|
$49.35M |
|
$41.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.93 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
93.37% |
|
-13.53% |
|
-13.53% |
|
7.05% |
|
1.51% |
|
-2.41% |
|
$77.41M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.78 |
|
3.94 |
|
92.70 |
|
-0.49% |
|
-0.88% |
|
-0.43% |
|
-0.49% |
|
$43.46 |
|
$4.23 |
|
$5.31 |
|